a phase iii study to evaluate the safety and efficacy of ganciclovir (dihydroxypropoxymethyl guanine [dhpg]) treatment of symptomatic central nervous system (cns) congenital cytomegalovirus (cmv) infections. trials will be used in what medical treatments?
(AND medicine.medical_treatment (JOIN medicine.medical_treatment.trials m.03zbbyd))